SenesTech President, CEO Joel Fruendt Intends To Retire, Effective June 30; Chair Jamie Bechtel Named Interim Executive Chair

SenesTech, Inc. (Nasdaq: SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

Mr. Fruendt joined SenesTech in 2022 and has overseen the Company's development and launch of its revolutionary new product, Evolve®, across multiple retail and professional channels.

In addition, to further support this transition, the Board has appointed Dr. Jamie Bechtel, current Chair of the Board, to the newly created role of Interim Executive Chair. In this role, Dr. Bechtel will partner with management to support strategic alignment, execution discipline, and clear communication between the Board and the leadership team. This position is intended to reinforce management accountability and ensure continuity – without assuming day-to-day operational responsibilities.